Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


European Notebook: Salmonson Stays At CHMP Helm; Sandoz, AstraZeneca Build New Biologics Facilities

Executive Summary

CHMP Chairman Tomas Salmonson re-elected for three-year term; Sandoz and AstraZeneca develop manufacturing facilities in Austria and the US respectively for biosimilars and biologics, among investments suggesting European pharmas' more confident outlook; more in this month's column


Related Content

French Industry Rages Over €1.7bn Drug Savings Plan
When Can You Ban Parallel Trade?
Lilly and Boehringer Ingelheim Launch Biosimilar Lantus In UK, Germany
European Notebook: EMA Conflict Of Interest Rules; EU Unitary Patent; EMA Adverse Event Literature Screening
For Pfizer Chief, The First Order Of Business Is Research


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts